Get started
Author

Shafqat Inam

Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors
2022 · Ana M. Metelo, Agnieszka Jozwik, et al. · Cancer Research Communications · 34
PDF
Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity
2020 · Elisaveta Sokolov, Philipp Karschnia, et al. · BMJ Neurology Open · 31
PDF
The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis
2010 · Shafqat Inam, Steve Vucic, et al. · Amyotrophic Lateral Sclerosis · 27
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
2024 · Michelle A. Neller, George R. Ambalathingal, et al. · Nature Communications · 26
PDF
Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/ΔFosB–VCAM-1 axis
2020 · Yue Li, Ahmad M. N. Alhendi, et al. · Science Advances · 26
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years
2019 · Vipul Sharad Sheth, Victoria Potter, et al. · Blood Advances · 24
PDF
Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma
2021 · Mili Shah, Andrea Kuhnl, et al. · HemaSphere · 20
Neurotoxicity associated with chimeric antigen receptor T-cell therapy
2025 · Miriam Wronski, Robb Wesselingh, et al. · Journal of Neuroimmunology · 15
Radiation Exposure During Cardiac Catheterisation is Similar for Both Femoral and Radial Approaches
2014 · Belinda Gray, Harry Klimis, et al. · Heart Lung and Circulation · 14
GB261, an Fc-Function Enabled and CD3 Affinity De-Tuned CD20/CD3 Bispecific Antibody, Demonstrated a Highly Advantageous Safety/Efficacy Balance in an Ongoing First-in-Human Dose-Escalation Study in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
2023 · Yuqin Song, Zengjun Li, et al. · Blood · 13
Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
2024 · Joshua W. D. Tobin, Greg Hapgood, et al. · Internal Medicine Journal · 7
PDF
CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allogeneic Stem Cell Transplant Recipients With Acute Myeloid Leukaemia/Myelodysplastic Syndrome
2024 · Joanne LC Tan, David J Curtis, et al. · Clinical Lymphoma Myeloma & Leukemia · 4
Impact of Medication Adherence by Using Indian Version Compliance Questionnaire Rheumatology (Cqr) and Medication Adherence Report Scale (Mars) Tools on Quality of Life of Patients With Rheumatoid Arthritis
2014 · R. Shetty, K. Reddy, et al. · Value in Health · 4
PDF
Low-intensity venetoclax-based salvage as a bridge to allogeneic stem cell transplant in patients with acute myeloid leukemia failing conventional intensive chemotherapy
2023 · Michael Ashby, Shaun Fleming, et al. · Leukemia Research · 3
Secondary Diffuse Choroid Plexus B-Cell Lymphoma: Case Report and Review of Literature
2019 · Bi Yi Chen, Vivien Chen, et al. · World Neurosurgery · 3
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
2026 · Mark R. Dowling, Edward R. Scheffer Cliff, et al. · Blood · 2
Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Utility for Subacute Cognitive Monitoring after Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T-Cell Therapy
2025 · Christina Kazzi, Sarah P. Griffith, et al. · Transplantation and Cellular Therapy · 2
A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium
2025 · Mark Dowling, Vinay Vanguru, et al. · Blood · 2
Monitoring the neurological complications of chimeric antigen receptor (CAR) T-cell therapy in patients with sensory and physical impairments and non-native-speaking backgrounds using modified immune effector cell-associated encephalopathy (ICE) scores: a case series
2025 · Christina Kazzi, Ty Simpson, et al. · BMJ Neurology Open · 2
PDF
Third-Party Partially HLA Matched Fungus-Specific T-Cells (FSTs) Used to Treat Invasive Fungal Infection (IFI) with Scedosporium Aurantiacum after Allogeneic Hemopoietic Stem Cell Transplant (aHSCT)
2021 · Shafqat Inam, Gaurav Sutrave, et al. · Blood · 2
Paving the way to precision medicine in multiple myeloma
2021 · Shafqat Inam, Jeremy A. Ross, et al. · Expert Review of Hematology · 2
A Computerized Cognitive Test for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T-Cell Therapy Recipients: A Pilot Study
2026 · Christina Kazzi, David Darby, et al. · Transplantation and Cellular Therapy · 1
Supporting the Shift: Inpatient Review of BCMA CAR-T Therapy in Multiple Myeloma Reveals Early Safety and Feasibility for a Nurse Lead Outpatient Model of Care
2025 · Ty Simpson, Sriyani Parsons, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell‐associated neurotoxicity syndrome following chimeric antigen receptor T‐cell therapy
2025 · Christina Kazzi, Ty Simpson, et al. · British Journal of Haematology · 1
PDF
Abs1055 Gb261 (cnd261), a Novel Cd20/cd3 T-cell Engager, Has a Differentiated Safety Profile and Potential for Development in Autoimmune Diseases
2025 · Y. Song, Z. Li, et al. · Annals of the Rheumatic Diseases · 1
Works count: 52
Citation count: 269
H-index: 10
I10-index: 10
Year
Topic
Type